Challenges and benefits of endogenous steroid analysis by LC-MS/MS

Bioanalysis

Volumn 3, Issue 22, 2011, Pages 2549-2572

  Couchman, Lewis ^a   Vincent, Royce P ^a   Ghataore, Lea ^a   Moniz, Caje F ^a   Taylor, Norman F ^a  

^a KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

STEROID;

ACCURACY; BLOOD SAMPLING; CALIBRATION; DERIVATIZATION; DRIED BLOOD SPOT; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; IONIZATION; LIMIT OF DETECTION; LIQUID CHROMATOGRAPHY; PROCESS DEVELOPMENT; REVIEW; SALIVA ANALYSIS; SENSITIVITY ANALYSIS; STANDARDIZATION; STEROID ANALYSIS; STEROID BLOOD LEVEL; STEROID URINE LEVEL; STRUCTURE ANALYSIS; TANDEM MASS SPECTROMETRY; VALIDATION PROCESS;

ANIMALS; CHROMATOGRAPHY, LIQUID; FEMALE; HUMANS; MALE; STEROIDS; TANDEM MASS SPECTROMETRY;

EID: 82455168273     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.11.254     Document Type: Review

References (180)

1. Guo T, Taylor RL, Singh RJ et al. Simultaneous determination of 12 steroids by isotope dilution liquid chromatography-photospray ionization tandem mass spectrometry. Clin. Chim. Acta 372, 76-82 (2006).
2. Fanelli F, Belluomo I, Di Lallo VD et al. Serum steroid profiling by isotopic dilution-liquid chromatography-tandem mass spectrometry: comparison with current immunoassays and reference intervals in healthy adults. Steroids 76, 244-253 (2011).
3. Dooley KC. Tandem mass spectrometry in the clinical chemistry laboratory. Clin. Biochem. 36, 471-481 (2003).
4. Vogeser M, Seger C. A decade of HPLC-MS/MS in the routine clinical laboratory - goals for further developments. Clin. Biochem. 41, 649-662 (2008).
5. Vogeser M, Seger C. Pitfalls associated with the use of liquid chromatography-tandem mass spectrometry in the clinical laboratory. Clin. Chem. 56, 1234-1244 (2010).
6. Honour JW. Development and validation of a quantitative assay based on tandem mass spectrometry. Ann. Clin. Biochem. 48, 97-111 (2011).
7. Yalow RS, Berson SA. Assay of plasma insulin in human subjects by immunological methods. Nature 184, 1648-1649 (1959).
8. Ekins RP. The estimation of thyroxine in human plasma by an electrophoretic method. Clin. Chim. Acta 3, 453-459 (1960).
9. Abraham GE. Solid phase radioimmunoassay of estradiol-17b. J. Clin. Endocr. 29, 866-870 (1969).
10. Erlanger BF, Borek F, Beiser SM et al. Steroid-protein conjugates 1. Preparation and characterization of conjugates of bovine serum albumin with testosterone and with cortisone. J. Biol. Chem. 228, 713-727 (1957).
11. Midgley AR, Niswender GD. Radioimmunoassay of steroids. Acta Endocr. (Copenh) 65, S320-S331 (1970).
12. Wong T, Shackleton CH, Covey TR et al. Identification of the steroids in neonatal plasma that interfere with 17a-hydroxyprogesterone radioimmunoassay. Clin. Chem. 38, 1830-1837 (1992).
13. Heald AH, Butterworth A, Kane JW et al. Investigation into possible causes of interference in serum testosterone measurement in women. Ann. Clin. Biochem. 43, 189-195 (2006).
14. Stanczyk FZ, Lee JS, Santen RJ. Standardization of steroid hormone assays: why, how and when? Cancer Epidemiol. Biomarkers Prev. 16, 1713-1719 (2007).
15. Gallagher LM, Owen LJ, Keevil BG. Simultaneous determination of androstenedione and testosterone in human serum by liquid chromatography-tandem mass spectrometry. Ann. Clin. Biochem. 44, 48-56 (2007).
16. Kushnir MM, Blamires T, Roberts WL et al. LC-MS/MS assay for androstenedione, dehydroepiandrosterone and testosterone with pediatric and adult reference intervals. Clin. Chem. 56, 1138-1147 (2010).
17. Kushnir MM, Rockwood AL, Robert WL et al. Development and performance evaluation of a tandem mass spectrometry assay for 4 adrenal steroids. Clin. Chem. 52, 1559-1567 (2006).
18. Rossi C, Calton L, Hammond G et al. Serum steroid profiling for congenital adrenal hyperplasia using liquid chromatography- tandem mass spectrometry. Clin. Chim. Acta 411, 222-228 (2010).
19. Wang C, Catlin DH, Demers LM et al. Measurement of total serum testosterone in adult men: comparison of current laboratory methods versus liquid chromatography- tandem mass spectrometry. J. Clin. Endocrinol. Metab. 89, 534-543 (2004).
20. Taieb J, Mathian B, Millot F et al. Testosterone measured by 10 immunoassays and isotope-dilution gas chromatography- mass spectrometry in sera from 166 men, women, and children. Clin. Chem. 49, 1381-1395 (2003).
21. Eibs G, Schöneshöfer M. Simultaneous determination of fifteen steroid hormones from a single serum sample by high-performance liquid chromatography and radioimmunoassay. J. Chromatogr. 310, 386-389 (1984).
22. Chen Y, Yazdanpanah M, Hoffman BR et al. Rapid determination of serum testosterone by liquid chromatography-isotope dilution tandem mass spectrometry and a split sample comparison with three automated immunoassays. Clin. Biochem. 42, 484-490 (2009).
23. Ghataore L, Couchman L, Vincent RP et al. Simultaneous analysis of a steroid panel in human serum by LC-MS/MS: comparison with immunoassay. Ann. Clin. Biochem. 48(Suppl. 1), 74 (2011).
24. Herold DA, Fitzgerald RL. Immunoassays for testosterone in women: better than a guess? Clin. Chem. 49, 1250-1251 (2003).
25. Rosner W, Auchus RJ, Azziz R et al. Position statement: utility, limitations, and pitfalls in measuring testosterone: an endocrine society position statement. J. Clin. Endocrinol. Metab. 92, 405-413 (2007).
26. Shackleton C. Clinical steroid mass spectrometry: a 45-year history culminating in HPLC-MS/MS becoming an essential tool for patient diagnosis. J. Steroid Biochem. 121, 481-490 (2010).
27. Rauh M. Steroid measurement with LC-MS/MS in pediatric endocrinology. Mol. Cell Endocrinol. 301, 272-281 (2009).
28. Janzen M, Peter M, Sander S et al. Newborn screening for congenital adrenal hyperplasia: additional steroid profile using liquid chromatography-tandem mass spectrometry. J. Clin. Endocrinol. Metab. 92, 2581-2589 (2007).
29. Demers LM. Androgen deficiency in women; role of accurate testosterone measurements. Maturitas 67, 39-45 (2010).
30. Marsden D, Larson CA. Emerging role for tandem mass spectrometry in detecting congenital adrenal hyperplasia. Clin. Chem. 50, 467-468 (2004).
31. Thienpoint LM, De Brabandere VI, Stöckl D, De Leenheer AP. Candidate reference method for determining serum cortisol based on isotope dilution-gas chromatography-mass spectrometry using heptafluorobutyrilation as derivatisation method. Anal. Biochem. 234, 204-209 (1996).
32. Wudy SA, Hartmann MF. Gas chromatography-mass spectrometry profiling of steroids in times of molecular biology. Horm. Metab. Res. 36, 415-422 (2004).
33. Wudy SA, Hartmann M, Homoki J. Hormonal diagnosis of 21-hydroxylase deficiency in plasma and urine of neonates using benchtop gas chromatography-mass spectrometry. J. Endocrinol. 165, 679-683 (2000).
34. Krone N, Hughes B, Lavery GG et al. Gas chromatography-mass spectrometry (GC-MS) remains a pre-eminent discovery tool in clinical steroid investigations even in the era of fast liquid chromatography-tandem mass spectrometry (LC-MS/MS).J. Steroid Biochem. Mol. Biol. 121, 496-504 (2010).
35. Christakoudi S, Cowan DA, Taylor NF. Steroids excreted in urine by neonates with 21-hydroxylase deficiency: characterisation, using GC-MS, and GC-MS/MS, of the D-ring and side chain structure of pregnanes and pregnenes. Steroids 75, 34-52 (2010).
36. Christakoudi S, Cowan DA, Taylor NF. A new marker for early diagnosis of 21-hydroxylase deficiency: 3b,16a,17a-trihydroxy-5a-pregnane-7,20-dione. J. Steroid Biochem. Mol. Biol. 121, 574-581 (2010).
37. Hill M, Parizek, A, Kancheva R et al. Steroid metabolome in plasma from the umbilical artery, umbilical vein, maternal antecubital vein and in amniotic fluid in normal and preterm labor. J. Steroid Biochem. Mol. Biol. 121, 594-610 (2010).
38. Flanagan RJ, Whelpton R, Watson ID et al. Fundamentals of Analytical Toxicology. John Wiley and Sons Ltd, London (2007).
39. Couchman L, Morgan PE. LC-MS in analytical toxicology: some practical considerations. Biomed. Chromatogr. 25, 100-123 (2011).
40. Guillarme D, Ruta J, Rudaz S et al. New trends in fast and high-resolution liquid chromatography: a critical comparison of existing approaches. Anal. Bioanal. Chem. 397, 1069-1082 (2010).
41. Ceglarek U, Werner M, Kortx L et al. Preclinical challenges in steroid analysis of human samples. J. Steroid Biochem. 121, 505-512 (2010).
42. Kirchhoff F, Briegel J, Vogeser M. Quantification of free serum cortisol based on equilibrium dialysis and isotope dilution-liquid chromatography-tandem mass spectrometry. Clin. Biochem. 44, 894-899 (2011).
43. Chen Y, Yazdanpanah M, Wang XY et al. Direct measurement of serum free testosterone by ultrafiltration followed by liquid chromatography-tandem mass spectreometry. Clin. Biochem. 43, 490-496 (2010).
44. Sodergard R, Backstrom T, Shanbhag V et al. Calculation of free and bound fractions of testosterone and estradiol 17b to human plasma protein at body temperature. J. Steroid Biochem. 26, 801-810 (1982).
45. Vermuelen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J. Clin. Endocrinol. Metab. 84, 3666-3672 (1999).
46. Hackbarth JS, Hoyne JB, Grebe SK et al. Accuracy of calculated free testosterone differs between equations and depends on gender and SHBG concentration. Steroids 76, 48-55 (2011).
47. MacDonald PR, Owen LJ, Wu FC et al. A liquid chromatography-tandem mass spectrometry method for salivary testosterone with adult male reference interval determination. Clin. Chem. 57(5), 774-781 (2011).
48. Liening SH, Stanton SJ, Saini EK et al. Salivary testosterone, cortisol and progesterone: two-week stability, interhormone correlations, and effects of time of day, menstrual cycle and oral contraception use on hormone levels. Physiol. Behav. 99, 8-16 (2010).
49. Shaw MA, Back DJ. Adsorption of pregnanediol 3-a-glucuronide by plastics and glass. J. Steroid Biochem. 19, 1681-1682 (1983).
50. Kushnir MM, Neilson R, Roberts WL et al. Cortisol and cortisone analysis in serum and plasma by atmospheric pressure photoionization tandem mass spectrometry. Clin. Biochem. 37, 357-362 (2004).
51. Stanczyk FZ, Clarke NJ. Advantages and challenges of mass spectrometry assays for steroid hormones. J. Steroid Biochem. 121, 491-495 (2010).
52. Wang C, Shiraishi S, Leung A et al. Validation of a testosterone and dihydrotestosterone liquid chromatography- tandem mass spectrometry assay: interference and comparison with established methods. Steroids 73, 1345-1352 (2008).
53. Annesley TM. Ion suppression in mass spectrometry. Clin. Chem. 49, 1041-1044 (2003).
54. Annesley TM. Methanol-associated matrix effects in electrospray ionization tandem mass spectrometry. Clin. Chem. 53, 1827-1834 (2007).
55. Taylor PJ. Matrix effects: the Achilles heel of quantitative high performance liquid chromatography-electrospray-tandem mass spectrometry. Clin. Biochem. 38, 328-334 (2005).
56. Capiello A, Famiglini G, Palma P et al. Matrix effects in liquid chromatography-mass spectrometry. J. Liq. Chromatogr. Relat. Technol. 33, 1067-1081 (2010).
57. Gosetti F, Mazzucco E, Zampieri D et al. Signal suppression/enhancement in high-performance liquid chromatography- tandem mass spectrometry. J. Chromatogr. A 1217, 3929-3937 (2010).
58. Bonfiglio R, King RC, Olah TV et al. The effects of sample preparation methods on the variability of the electrospray ionization response for model drug compounds. Rapid Commun. Mass Spectrom. 13, 1175-1185 (1999).
59. Matuszewski BK, Constanzer ML, Chavez- Eng CM. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal. Chem. 75, 3019-3030 (2003).
60. van Eeckhaut A, Lanckmans K, Sarre S et al. Validation of bioanalytical LC-MS/MS assays: evaluation of matrix effects. J. Chromatogr. B 877, 2198-2207 (2009).
61. Srinivas NR. Dodging matrix effects in liquid chromatography-tandem mass spectrometric assays - compilation of key learnings and perspectives. Biomed. Chromatogr. 23, 451-454 (2009).
62. Bunch DR, Miller AY, Wang S. Development and validation of a liquid chromatography- tandem mass spectrometry assay for serum 25-hydroxyvitamin D2/D3 using a turbulent flow online extraction technology. Clin. Chem. Lab. Med. 47, 1565-1572 (2009).
63. Sojo LE, Lum G, Chee P. Internal standard signal suppression by co-eluting analyte in isotope dilution LC-ESI-MS. Analyst 128, 51-55 (2003).
64. Stovkis E, Rosing H, Beijnen JH. Stable isotopically labeled internal standards in quantitative bioanalysis using liquid chromatography-mass spectrometry: necessary or not? Rapid Commun. Mass Spectrom. 19, 401-407 (2005).
65. Wang S, Cyronak M, Yang E. Does a stable isotopically labeled internal standard always correct analyte response? A matrix effect study on a LC-MS/MS method for the determination of carvediol enantiomers in human plasma. J. Pharmaceut. Biomed. 43, 701-707 (2007).
66. Lindegardh N, Annerberg A, White NJ et al. Development and validation of a liquid chromatographic-tandem mass spectrometric method for determination of piperaquine in plasma. Stable isotope labeled internal standard does not always compensate for matrix effects. J. Chromatogr. B 862, 227-236 (2008).
67. Tan A, Hussain S, Musuku A et al. Internal standard response variation during incurred sample analysis by LC-MS/MS: case by case trouble-shooting. J. Chromatogr. B 877, 3201-3209 (2009).
68. Kushnir MM, Rockwood AL, Roberts WL et al. Liquid chromatography-tandem mass spectrometry for analysis of steroids in clinical laboratories. Clin. Biochem. 44, 77-88 (2011).
69. Pozo OJ, van Eenoo P, Thuyne WV et al. Direct quantification of steroid glucuronides in human urine by liquid chromatography- electrospray mass spectrometry. J. Chromatogr. A 1183, 108-118 (2008).
70. Penning TM, Lee SH, Jin Y et al. Liquid chromatography-mass spectrometry (LC-MS) of steroid hormone metabolites and its applications. J. Steroid Biochem. 121, 546-555 (2010).
71. Badoud F, Grata E, Boccard J et al. Quantification of glucuronidated and sulfated steroids in human urine by ultra-high pressure liquid chromatography quadrupole time-of-flight mass spectrometry. Anal. Bioanal. Chem. 400, 503-516 (2011).
72. Xu X, Roman JM, Issaq HJ et al. Quantitative measurement of endogenous estrogens and estrogen metabolites in human serum by liquid chromatography- tandem mass spectrometry. Anal. Chem. 79, 7813-7821 (2007).
73. Cho H-J, Kim JD, Lee W-Y et al. Quantitative metabolic profiling of 21 endogenous corticosteroids in urine by liquid chromatography-triple quadrupole mass spectrometry. Anal. Chim. Acta 632, 101-108 (2009).
74. Zhan Y, Musteata FM, Basset FA et al. Determination of nonconjugated and deconjugated testosterone and epitestosterone in urine using SPME: LC-MS/MS. Bioanalysis 3, 23-30 (2011).
75. Yamashita K, Nakagawa R, Okuyama M et al. Simultaneous determination of tetrahydrocortisol, allotetrahydrocortisol and tetrahydrocortisone in human urine by liquid chromatography-electrospray ionization tandem mass spectrometry. Steroids 73, 727-737 (2008).
76. Yuan C, Kosewick J, He X et al. Sensitive analysis of serum 1a,25-dihydroxyvitamin D by liquid chromatography-tandem mass spectrometry after removing interference with immunoaffinity extraction. Rapid Commun. Mass Spectrom. 25, 1241-1249 (2011).
77. Hosogi J, Tanaka H, Fujita K et al. LC-MS/MS coupled with immunoaffinity extraction for determination of estrone, 17b -estradiol and estrone 3-sulfate in human plasma. J. Chromatogr. B 878, 222-227 (2010).
78. Vogeser M, Kirchhoff F. Progress in automation of LC-MS in laboratory medicine. Clin. Biochem. 44, 4-13 (2011).
79. Magnusson MO, Sandstrom R. Quantitative analysis of eight testosterone metabolites using column switching and liquid chromatography-tandem mass spectrometry. Rapid Commun. Mass Spectrom. 18, 1089-1094 (2004).
80. Rauh M, Groschl M, Rascher W et al. Automated, fast and sensitive quantification of 17a-hydroxy-progesterone, androstenedione and testosterone by tandem mass spectrometry with on-line extraction. Steroids 71, 450-458 (2006).
81. Singh RJ. Validation of a high throughput method for serum/plasma testosterone using liquid chromatography-tandem mass spectrometry (LC-MS/MS).Steroids 73, 1339-1344 (2008).
82. Salameh WA, Redor-Goldman MM, Clarke NJ et al. Validation of a total testosterone assay using high-turbulence liquid chromatography-tandem mass spectrometry: total and free reference ranges. Steroids 75, 169-175 (2010).
83. Wright M, Couchman L, Halsall DJ. Turbulent flow liquid chromatography- tandem mass spectrometry for the analysis of bio-available testosterone in serum. Endoc. Abstracts 25, 76 (2011).
84. Ahmadkhaniha R, Shafiee A, Rastkari N et al. Quantification of endogenous steroids in urine by gas chromatography mass spectrometry using a surrogate analyte approach. J. Chromatogr. B 878, 845-852 (2010).
85. Couchman L, Ghataore L, Vincent RP et al. Rapid, simultaneous measurement of multiple steroids in human serum by LC-MS/MS. Ann. Clin. Biochem. 48(Suppl. 1), 38 (2011).
86. Miller JN, Miller JC. Statistics and Chemometrics for Analytical Chemistry, 5th Edition. Pearson Education Ltd., Essex, UK.
87. Li W, Cohen LH. Quantitation of endogenous analytes in biofluid without a true blank matrix. Anal. Chem. 75, 5854-5859 (2003).
88. Lien GW, Chen CY, Wang GS. Comparison of electrospray ionization, atmospheric pressure chemical ionization and atmospheric pressure photoionization for determining estrogenic chemicals in water by liquid chromatography-tandem mass spectrometry with chemical derivatizations. J. Chromatogr. A 1216, 956-966 (2009).
89. Guan F, Uboh CE, Soma LR et al. High-throughput UHPLC-MS/MS method for the detection, quantification and identification of fifty-five anabolic and androgenic steroids in equine plasma. J. Mass Spectrom. 45, 1270-1279 (2010).
90. Kushnir MM, Rockwood AL, Bergquist J et al. High-sensitivity tandem mass spectrometry assay for serum estrone and estradiol. Am. J. Clin. Pathol. 129, 530-539 (2008).
91. O'Hare MJ, Nice EC, Capp M. Reversed- and normal-phase high-performance liquid chromatography of 18-hydroxylated steroids and their derivatives. Comparison of selectivity, efficiency and recovery from biological samples. J. Chromatogr. 198, 23-39 (1980).
92. Blair IA. Analysis of estrogens in serum and plasma from postmenopausal women: past, present and future. Steroids 75, 297-306 (2010).
93. Rangiah K, Shah SJ, Vachani A et al. Liquid chromatography-mass spectrometry of pre-ionized Girard P derivatives for quantifying estrone and its metabolites in serum from postmenopausal women. Rapid Commun. Mass Spectrom. 25, 1297-1307 (2011).
94. Guo T, Chan M, Soldin SJ. Steroid profiles using liquid chromatography-tandem mass spectrometry with atmospheric pressure photoionization source. Arch. Pathol. Lab. Med. 128, 469-475 (2004).
95. Soldin SJ, Soldin OP. Steroid hormone analysis by tandem mass spectrometry. Clin. Chem. 55, 1061-1066 (2009).
96. Alary JF. Comparative LC-MS/MS analysis of four steroid compounds using a new photoionization source and a conventional APCI source. Presented at: The 49th ASMS Conference on Mass Spectrometry and Allied Topics. Am. Soc. Mass Spectrom. (2001).
97. Schuhmacher J, Zimmer D, Tesche F et al. Matrix effects during analysis of plasma samples by electrospray and atmospheric pressure chemical ionization mass spectrometry: practical approaches to their elimination. Rapid Commun. Mass Spectrom. 17, 1950-1957 (2003).
98. Matuzewski BK. Standard line slopes as a measure of a relative matrix effect in quantitative HPLC-MS bioanalysis. J. Chromatogr. B 830, 293-300 (2006).
99. Diaz-Cruz MS, de Alda MJL, Lopez R et al. Determination of estrogens and progestogens by mass spectrometric techniques (GC-MS, LC-MS and LC-MS/MS).J. Mass Spectrom. 38, 917-923 (2003).
100. Hsu JF, Chang YC, Chen TH et al. Evaluation of electrospray ionization and atmospheric pressure chemical ionization for simultaneous detection of estrone and its metabolites using high-performance liquid chromatography-tandem mass spectrometry. J. Chromatogr. B 860, 49-56 (2007).
101. Higashi T, Takayama N, Shimada K. Enzymic conversion of 3B-hydroxy-5-ene-steroids and their sulfates to 3-oxo-4-ene-steroids for increasing sensitivity in LC-APCI-MS. J. Pharmaceut. Biomed. 39, 718-723 (2005).
102. Higashi T, Shibayama Y, Kawasaki I et al. Determination of salivary 17-ketosteroid sulfates using liquid-chromatography- electrospray ionisation-mass spectrometry. J. Pharmaceut. Biomed. 43, 1782-1788 (2007).
103. Williams TM, Kind AJ, Houghton E et al. Electrospray collision-induced dissociation of testosterone and testosterone hydroxyl analogs. J. Mass Spectrom. 34, 206-216 (1999).
104. Cowan DA, Kicman AT, Kubli-Garflas C et al. Ion trap MS/MS of intact testosterone and epitestosterone conjugates - adducts, fragile ions and the advantages of derivatisation. Steroids 73, 621-628 (2008).
105. Pozo OJ, van Eenoo P, Deventer K et al. Ionization of anabolic steroids by adduct formation in liquid chromatography electrospray mass spectrometry. J. Mass Spectrom. 42, 497-516 (2007).
106. Keller BO, Sui J, Young AB et al. Interferences and contaminants encountered in modern mass spectrometry. Anal. Chim. Acta 627, 71-81 (2008).
107. Pozo OJ, van Eenoo P, Deventer K et al. Collision-induced dissociation of 3-keto anabolic steroids and related compounds after electrospray ionization. Considerations for structural elucidation. Rapid Commun. Mass Spectrom. 22, 4009-4024 (2008).
108. Guo T, Gu J, Soldin OP et al. Rapid measurement of estrogens and their metabolites in human serum by liquid chromatography-tandem mass spectrometry without derivatization. Clin. Biochem. 41, 736-741 (2008).
109. Harwood DT, Handelsman DJ. Development and validation of a sensitive liquid chromatography-tandem mass spectrometry assay to simultaneously measure androgens and estrogens in serum without derivatization. Clin. Chim. Acta 409, 78-84 (2009).
110. Higashi T, Shimada K. Derivatization of neural steroids to enhance their detection characteristics in liquid chromatography- mass spectrometry. Anal. Bioanal. Chem. 378, 875-882 (2004).
111. Iwasaki Y, Nakano Y, Mochizuki K et al. A new strategy for ionization enhancement by derivatization for mass spectrometry. J. Chromatogr. B 879, 1159-1165 (2011).
112. Rockwood AL, Kushnir MM. Use of derivatization for LC-MS/MS analysis in the clinical laboratory. Clin. Chim. Acta 411, 904 (2010).
113. Rauh M. Steroid measurement with LC-MS/ MS. Application examples in pediatrics. J. Steroid Biochem. 121, 520-527 (2010).
114. Falk RT, Xu X, Keefer L et al. A liquid chromatography-mass spectrometry method for the simultaneous measurement of 15 urinary estrogens and estrogen metabolites: assay reproducibility and interindividual variability. Cancer Epidemiol. Biomarkers Prev. 17, 3411-3418 (2008).
115. Nelson RE, Grebe SK, O'Kane DJ et al. Liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of estradiol and estrone in human plasma. Clin. Chem. 50, 373-384 (2004).
116. Xia YQ, Chang SW, Patel S et al. Trace level quantification of deuterated 17b-estradiol and estrone in ovariectomized mouse plasma and brain using liquid chromatography-tandem mass spectrometry following dansylation reaction. Rapid Commun. Mass Spectrom. 18, 1621-1628 (2004).
117. Yamashita K, Okuyama M, Watanabe Y et al. Highly sensitive determination of estrone and estradiol in human serum by liquid chromatography-electrospray ionization tandem mass spectrometry. Steroids 72, 819-827 (2007).
118. Weng Y, Xie F, Xu L et al. Analysis of testosterone and dihydrotestosterone in mouse tissues by liquid chromatography-electrospray ionisation-tandem mass spectrometry. Anal. Biochem. 402, 121-128 (2010).
119. Higashi T, Yamauchi K, Shimada K. 2-hydrazino-1-methylpyridine: a highly sensitive derivatization reagent for oxosteroids in liquid chromatography- electrospray ionization-mass spectrometry. J. Chromatogr. B 825, 214-222 (2005).
120. Kalhorn TF, Page ST, Howald WN et al. Analysis of testosterone and dihydrotestosterone from biological fluids as the oxime derivatives using high-performance liquid chromatography-tandem mass spectrometry. Rapid Commun. Mass Spectrom. 21, 3200-3206 (2007).
121. Shibayama Y, Higashi T, Shimada K et al. Simultaneous determination of salivary testosterone and dehydroepiandrosterone using LC-MS/MS: method development and evaluation of applicability for diagnosis and medication for late-onset hypogonadism. J. Chromatogr. B 877, 2615-2623 (2009).
122. Kushnir MM, Rockwood AL, Yue B et al. High sensitivity measurement of estrone and estradiol in serum and plasma using LC-MS/MS. Methods Mol. Biol. 603, 219-228 (2010).
123. Kushnir MM, Rockwood AL, Nelson GJ et al. Liquid chromatography-tandem mass spectrometry analysis of urinary free cortisol. Clin. Chem. 49, 965-967 (2003).
124. Pozo OJ, Deventer K, van Eenoo P et al. Efficient approach for the comprehensive detection of unknown anabolic steroids and metabolites in human urine by liquid chromatography-electrospray-tandem mass spectrometry. Anal. Chem. 80, 1709-1720 (2008).
125. Guan F, Uboh CE, Soma LR et al. Correlation of product ion profiles with molecular structures of androgenic and anabolic steroids in ESI MS/MS. J. Mass Spectrom. 45, 1261-1269 (2010).
126. Becue H, van Poucke C, van Peteghem C. The use of library identification and common fragments for the identification of corticosteroids in forensic samples. Anal. Bioanal. Chem. 400, 2837-2846 (2011).
127. Yamashita K, Okuyama M, Nakagawa R et al. Development of sensitive derivatization method for aldosterone in liquid chromatography-electrospray ionization tandem mass spectrometry of corticosteroids. J. Chromatogr. A 1200, 114-121 (2008).
128. Pozo OJ, van Eenoo P, Deventer K et al. Comparison between triple quadrupole, time of flight analysers coupled to liquid chromatography for the detection of anabolic steroids in doping control analysis. Anal. Chim. Acta 684, 107-120 (2011).
129. Ceglarek U, Kortz L, Leichtle A et al. Rapid quantification of steroid patterns in human serum by on-line solid phase extraction combined with liquid chromatography-triple quadrupole linear ion trap mass spectrometry. Clin. Chim. Acta 401, 114-118 (2009).
130. Pozo OJ, Marcos J, Ventura R et al. Testosterone metabolism revisited: discovery of new metabolites. Anal. Bioanal. Chem. 398, 1759-1770 (2010).
131. Scarth JP, Spencer HA, Hudson SC et al. The application of in vitro technologies to study the metabolism of the androgenic/anabolic steroid stanozolol in the equine. Steroids 75, 57-69 (2010).
132. Rosner W, Vesper H. CDC workshop report improving steroid hormone measurements in patient care and translation research. Steroids 73, 1285 (2008).
133. Vesper HW, Botelho JC, Shacklady C et al. CDC project on standardizing steroid hormone measurements. Steroids 73, 1286-1292 (2008).
134. Vesper HW, Botelho JC. Standardization of testosterone measurements in humans. J. Steroid Biochem. Mol. Biol. 121, 513-519 (2010).
135. Thienpont LM, van Uytfanghe K, Blincko S et al. State-of-the-art of serum testosterone measurement by isotope dilution-liquid chromatography-tandem mass spectrometry. Clin. Chem. 54, 1290-1297 (2008).
136. Vesper HW, Bhasin S, Wang C et al. Interlaboratory comparison study of serum total testosterone measurements performed by mass spectrometry methods. Steroids 74, 498-503 (2009).
137. Carter GD. Accuracy of 25-hydroxyvitamin D assays: confronting the issues. Curr. Drug Targets 12, 19-28 (2011).
138. Carter GD, Jones JC. Use of a common standard improves the performance of liquid chromatography-tandem mass spectrometry methods for serum 25-hydroxyvitamin-D. Ann. Clin. Biochem. 46, 79-81 (2009).
139. Tai SSC, Welch MJ. Development and evaluation of a candidate reference method for the determination of total cortisol in human serum using ID-LC-MS and LC-MS/MS. Anal. Chem. 76, 1008-1014 (2004).
140. Tai SSC, Welch MJ. Development and evaluation of a reference measurement procedure for the determination of estradiol-17B in human serum using ID-LC-MS/MS. Anal. Chem. 77, 6359-6363 (2005).
141. Tai SSC, Xu B, Welch MJ. Development and evaluation of a candidate reference measurement procedure for the determination of progesterone in human serum using ID-LC-MS/MS. Anal. Chem. 78, 6628-6633 (2006).
142. Tai SSC, Xu B, Welch MJ et al. Development and evaluation of a candidate reference measurement procedure for the determination of testosterone in human serum using isotope dilution liquid chromatography-tandem mass spectrometry. Anal. Bioanal. Chem. 388, 1087-1094 (2007).
143. Katayev A, Balciza C, Seccombe D. Establishing reference intervals for clinical laboratory test results: is there a better way? Am. J. Clin. Pathol. 133, 180-186 (2010).
144. Friedberg R, Souers R, Wagar E et al. The origin of reference intervals. Arch. Pathol. Lab. Med. 131, 348-357 (2007).
145. Nguyen HP, Gatson JW, Maass D et al. Simultaneous quantification of four native estrogen hormones at trace levels in human cerebrospinal fluid using liquid chromatography-tandem mass spectrometry. J. Pharmaceut. Biomed. 54, 830-837 (2011).
146. Chang YC, Li CM, Li LA et al. Quantitative measurement of male steroid hormones using automated on-line solid phase extraction-liquid chromatography-tandem mass spectrometry and comparison with radioimmunoassay. Analyst 128, 363-368 (2003).
147. Gazdar AF, Oie HK, Shackleton CH et al. Establishment and characterization of a human adrenocortical carcinoma cell line that express multiple pathways of steroid biosynthesis. Cancer Res. 50, 5488-5496 (1990).
148. Groschl M. Current status of salivary hormone analysis. Clin. Chem. 54(11), 1759-1769 (2008).
149. Dauber A, Kellogg M, Majzoub JA. Monitoring of therapy in congenital adrenal hyperplasia. Clin. Chem. 56(8), 1245-1251 (2010).
150. Carroll T, Raff H, Findling JW. Late night salivary cortisol measurement in the diagnosis of Cushing's syndrome. Nat. Clin. Pract. Endoc. 4(6), 344-350 (2008).
151. Raff H. Utility of salivary cortisol measurements in Cushing's syndrome and adrenal insufficiency. J. Clin. Endocr. Metab. 94, 3647-3655 (2009).
152. Sereg M, Toke J, Patocs A et al. Diagnostic performance of salivary cortisol and serum osteocalcin measurements in patients with overt and subclinical Cushing's syndrome. Steroids 76, 38-42 (2011).
153. Yasuda M, Honma S, Furuya K et al. Diagnostic significance of salivary testosterone measurement revisited: using liquid chromatography-mass spectrometry and enzyme-linked immunosorbent assay. J. Mens Health 5, 56-63 (2008).
154. Cardoso EML, Contreras LN, Tumilasci EG et al. Salivary testosterone for the diagnosis of androgen deficiency in end-stage renal disease. Nephrol. Dial. Transplant 26, 677-683 (2011).
155. Higashi T, Shibayama Y, Shimada K. Determination of salivary dehydroepiandrosterone using liquid chromatography-tandem mass spectrometry combined with charged derivatisation. J. Chromatogr. B 846, 195-201 (2007).
156. Shibayama Y, Higashi T, Shimada K et al. Liquid chromatography-tandem mass spectrometric method for the determination of salivary 17a- hydroxyprogesterone: a noninvasive tool for evaluating efficacy of hormone replacement therapy in congenital adrenal hyperplasia. J. Chromatogr. B 867, 49-56 (2008).
157. Wood P. Salivary steroid assays - research or routine? Ann. Clin. Biochem. 46, 183-196 (2009).
158. Jonsson BAG, Malmberg B, Amilon A et al. Determination of cortisol in saliva using liquid-chromatography-electrospray tandem mass spectrometry. J. Chromatogr. B 784, 63-68 (2003).
159. Kataoka H, Matsuura E, Mitani K. Determination of cortisol in human saliva by automated in-tube solid-phase microextraction coupled with liquid chromatography-mass spectrometry. J. Pharmaceut. Biomed. 44, 160-165 (2007).
160. Perogamvros I, Owen LJ, Newell-Price J et al. Simultaneous determination of cortisol and cortisone in human saliva using liquid chromatography-tandem mass spectrometry: application in basal and stimulated conditions. J. Chromatogr. B 877, 3771-3775 (2009).
161. Lewis JG. Steroid analysis in saliva: an overview. Clin. Biochem. Rev 27, 139-146 (2006).
162. Sarafoglou K, Himes JH, Lacey JM et al. Comparison of multiple steroid concentrations in serum and dried blood spots throughout the day of patients with congenital adrenal hyperplasia. Horm. Res. Paediatr. 75, 19-25 (2011).
163. Keevil BG. The analysis of dried blood spot samples using liquid chromatography-tandem mass spectrometry. Clin. Biochem. 44, 110-118 (2011).
164. Lacey JM, Minutti CZ, Magera MJ et al. Improved specificity of newborn screening for congenital adrenal hyperplasia by second-tier steroid profiling using tandem mass spectrometry. Clin. Chem. 50, 621-625 (2004).
165. Minutti CZ, Lacey JM, Magera MJ et al. Steroid profiling by tandem mass spectrometry improves the positive predictive value of newborn screening for congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 89, 3687-3693 (2004).
166. de Jesus VR, Simms, DA, Schiffer J et al. Pilot proficiency testing for second tier congenital adrenal hyperplasia newborn screening. Clin. Chim. Acta 411, 1684-1687 (2010).
167. Schwarz E, Liu A, Randall C et al. Use of steroid profiling by UPLC-MS/MS as a second tier test in newborn screening for congenital adrenal hyperplasia: the Utah experience. Pediatr. Res. 66, 230-235 (2009).
168. Rossi C, Calton L, Brown HA et al. Confirmation of congenital adrenal hyperplasia by adrenal steroid profiling of filter paper dried blood samples using ultra-performance liquid-chromatography- tandem mass spectrometry. Clin. Chem. Lab. Med. 49, 677-684 (2011).
169. Cristoni S, Cuccato D, Sciannamblo M et al. Analysis of 21-deoxycortisol, a marker of congenital adrenal hyperplasia, in blood by atmospheric pressure chemical ionization and electrospray ionization using multiple reaction monitoring. Rapid Commun. Mass Spectrom. 18, 77-82 (2004).
170. Janzen N, Sander S, Terhardt M et al. Fast and direct quantification of adrenal steroids by tandem mass spectrometry in serum and dried blood spots. J. Chromatogr. B 861, 117-122 (2008).
171. Chace DH, Kalas TA, Naylor EW. Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns. Clin. Chem. 49, 1797-1817 (2003).
172. Higashi T, Nishio T, Uchida S et al. Simultaneous determination of 17a-prenenolone and 17a-progesterone in dried blood spots from low birth weight infants using LC-MS/MS. J. Pharmaceut. Biomed. 48, 177-182 (2008).
173. Magnisali P, Chalioti MB, Livadara T et al. Simultaneous quantification of 17a-OH progesterone, 11-deoxycortisol, D4-androstenedione, cortisol and cortisone in newborn blood spots using liquid chromatography-tandem mass spectrometry. J. Chromatogr. B 879, 1565-1572 (2011).
174. Flores-Valverde AM, Hill EM. Methodology for profiling the steroid metabolome in animal tissues using ultraperformance liquid chromatography- electrospray-time-of-flight mass spectrometry. Anal. Chem. 80, 8771-8779 (2008).
175. Mazzarino M, Turi S, Botre F. A screening method for the detection of synthetic glucocorticoids in human urine by liquid chromatography-mass spectrometry based on class-characteristic fragmentation pathways. Anal. Bioanal. Chem. 390, 1389-1402 (2008).
176. Pozo OJ, Ventura R, Monfort N et al. Evaluation of different scan methods for the urinary detection of corticosteroid metabolites by liquid chromatography-tandem mass spectrometry. J. Mass Spectrom. 44, 929-944 (2009).
177. Holst JP, Soldin OP, Guo TD et al. Steroid hormones: relevance and measurement in the clinical laboratory. Clin. Lab. Med. 24, 105-118 (2004).
178. Holst JP, Soldin SJ, Tractenberg T et al. Use of steroid profiles in determining the cause of adrenal insufficiency. Steroids 72, 71-84 (2007).
179. Rothman MS, Carlson NE, Xu M et al. Reexamination of testosterone, dihydrotestosterone, estradiol and estrone levels across the menstrual cycle and in postmenopausal women measured by liquid chromatography-tandem mass spectrometry. Steroids 76, 177-182 (2011).
180. Berra M, Williams EL, Muroni B et al. Recognition of 5a-reductase-2 deficiency in an adult female 46XY DSD clinic. Eur. J. Endocrinol. 164, 1019-1025 (2011).